ViiV (i.e. GSK for all practical purposes) starts phase-3 trial of Selzentry+Prezista vs Truvada+Prezista: http://finance.yahoo.com/news/ViiV-Healthcare-Starts-Phase-prnews-2842047759.html?x=0&.v=1 Selzentry is called ‘Censentri’ in Europe.